-
Oh c’mon, Novartis
Luckily this shouldn’t affect any patients or the actual treatment: Novartis on Wednesday defended the company’s decision to delay telling the Food and Drug Administration about manipulated data
Here’s the direct FDA report which is a bit too dense for me to parse: https://www.fda.gov/media/129664/download
Sorry, there were no replies found.
Log in to reply.